Lianyue Song Files 13D for Hartford Great Health Corp.

Ticker: HFUS · Form: SC 13D · Filed: Mar 6, 2024 · CIK: 1482554

Hartford Great Health CORP. SC 13D Filing Summary
FieldDetail
CompanyHartford Great Health CORP. (HFUS)
Form TypeSC 13D
Filed DateMar 6, 2024
Risk Levelmedium
Pages5
Reading Time6 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: ownership-change, schedule-13d, corporate-filing

Related Tickers: HGHC

TL;DR

**Song Lianyue files 13D for Hartford Great Health Corp. (HGHC) - ownership change.**

AI Summary

On March 6, 2024, Lianyue Song filed a Schedule 13D for Hartford Great Health Corp. (formerly Photoamigo, Inc.). The filing indicates a change in beneficial ownership as of June 1, 2023. Song's address is listed as 8832 Glendon Way, Rosemead, CA 91770.

Why It Matters

This filing signals a potential shift in control or significant investment in Hartford Great Health Corp., requiring market participants to monitor the company's future actions and stock performance.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to increased volatility and uncertainty for the company's stock.

Key Players & Entities

FAQ

What is the CUSIP number for Hartford Great Health Corp. common stock?

The CUSIP number for Hartford Great Health Corp. common stock is 41653H106.

When was the event that required this Schedule 13D filing?

The date of the event which requires filing of this statement is June 1, 2023.

What was Hartford Great Health Corp. formerly known as?

Hartford Great Health Corp. was formerly known as Photoamigo, Inc.

Who is authorized to receive notices and communications for this filing?

Lianyue Song, at 8832 Glendon Way, Rosemead, CA 91770, is authorized to receive notices and communications.

What is the fiscal year end for Hartford Great Health Corp.?

The fiscal year end for Hartford Great Health Corp. is 0731.

Filing Stats: 1,402 words · 6 min read · ~5 pages · Grade level 12.3 · Accepted 2024-03-06 14:20:43

Key Financial Figures

Filing Documents

From the Filing

SC 13D 1 formsc13d.htm UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 HARTFORD GREAT HEALTH CORP. (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 41653H106 (CUSIP Number) Lianyue Song 8832 Glendon Way Rosemead, CA 91770 (626) 321-1915 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 1, 2023 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 36117V204 1 NAMES OF REPORTING PERSONS Lianyue Song 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS ( See Instructions) PF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) 6 CITIZENSHIP OR PLACE OF ORGANIZATION China NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 85,165,200 (1) 8 SHARED VOTING POWER 0 9 SOLE DISPOSITIVE POWER 85,165,200 (1) 10 SHARED DISPOSITIVE POWER 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 85,165,200 (1) 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ( See Instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 85% (1) 14 TYPE OF REPORTING PERSON ( See Instructions) IN (1) Based on 100,108,000 shares of Common Stock outstanding as of February 29, 2024, as reported by the Issuer to the Reporting Person. 2 Item 1. Security and the Issuer This Stock ”) of Hartford Great Health Corp., a company incorporated in the state of Nevada (the “ Issuer ” or “Company”). The address of the principal executive offices of the Issuer is 8832 Glendon Way, Rosemead, CA 91770. Item 2. Identity and Background Lianyue Song is an individual and an investor. Other than his ownership of common stock of the Issuer by himself, he does not own any other securities of the Issuer nor is a party to any contract, agreement or understanding required to be disclosed herein. During the last five years, Mr. Song has not been: (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Item 3. Source and Amount of Funds or Other Consideration The source of funds for the acquisition of shares of the Company was the personal funds of Mr. Song. Item 4. Purpose of Transaction As of the date hereof, the Reporting Persons do not have a plan or proposal that relates to or would result in any of the transactions enumerated in sub items (a) through (j) of the instructions to Item 4 of this Schedule 13D. Notwithstanding the foregoing, the Reporting Persons reserve the right to effect any such actions as any of them may deem necessary or appropriate in the future. Item 5. Interest in Securities of the Issuer (a) – (b) (a), (b) The Reporting Person, currently beneficially own 85,165,200 shares of Common Stock, which represents 85% of the outstanding shares of Common Stock of the Issuer. Such percentage and the percentages below are calculated based on 100,108,000 shares of Common Stock outstanding as of November 27, 2023 (as reported in the Issuer’s Form 10-Q filed with the SEC on December 12, 2023). The following summarizes the Reporting Persons’

View Full Filing

View this SC 13D filing on SEC EDGAR

View on Read The Filing